{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:47Z","timestamp":1790386667626,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Science and Technology, Govt. of India"},{"name":"Council of Scientific and Industrial Research (CSIR), India"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.biocel.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T19:21:27Z","timestamp":1466191287000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression"],"prefix":"10.1016","volume":"77","author":[{"given":"Subramaniam","family":"Agatheeswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2016.06.007_bib0005","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/leu.2012.339","article-title":"BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia","volume":"27","author":"Agatheeswaran","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2016.06.007_bib0010","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2016.06.007_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/onc.2013.56","article-title":"Myocyte enhancer factor 2c in haematopoiesis and leukemia","volume":"33","author":"Cant\u00e9-Barrett","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2016.06.007_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11899-012-0121-6","article-title":"Chronic myeloid leukemia stem cell biology","volume":"7","author":"Crews","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.biocel.2016.06.007_bib0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cell.2010.01.007","article-title":"miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts","volume":"140","author":"Eiring","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2016.06.007_bib0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cell.2005.09.023","article-title":"A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C\/EBPalpha regulates human granulopoiesis","volume":"123","author":"Fazi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2016.06.007_bib0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood-2006-01-011833","article-title":"Leukemogenesis induced by wild type and STI-571 resistant BCR\/ABL is potently suppressed by C\/ebpa","volume":"108","author":"Ferrari-Amorotti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2016.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2016.06.007_bib0045","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1093\/nar\/26.12.3034","article-title":"Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C\/EBP\u03b1","volume":"26","author":"Iwama","year":"1998","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.biocel.2016.06.007_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20040336","article-title":"Chronic myeloid leukaemia: stem cell derived but progenitor cell driven","volume":"109","author":"Marley","year":"2005","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.biocel.2016.06.007_bib0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ng791","article-title":"BCR-ABL suppresses C\/EBP alpha expression through inhibitory action of hnRNP E2","volume":"30","author":"Perrotti","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biocel.2016.06.007_bib0060","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biocel.2016.06.007_bib0065","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2007-10-116343","article-title":"The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate","volume":"111","author":"Schuler","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2016.06.007_bib0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2002-01-0043","article-title":"The effects of Bcr-Abl on C\/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate","volume":"101","author":"Schuster","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2016.06.007_bib0075","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2008-05-158196","article-title":"Homing and invasiveness of MLL\/ENL leukemic cells is regulated by MEF2C","volume":"114","author":"Schwieger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biocel.2016.06.007_bib0080","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1172\/JCI31988","article-title":"Applying the discovery of the Philadelphia chromosome","volume":"117","author":"Sherbenou","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biocel.2016.06.007_bib0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1694","article-title":"Regulation of lymphoid versus myeloid fate \u2018choice\u2019 by the transcription factor Mef2c","volume":"10","author":"Stehling-Sun","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biocel.2016.06.007_bib0090","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/leu.2011.325","article-title":"Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors","volume":"26","author":"Traer","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2016.06.007_bib0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ncb2698","article-title":"C\/ebpa controls acquisition and maintenance of adult HSC","volume":"15","author":"Ye","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biocel.2016.06.007_bib0100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP\u03b1","volume":"21","author":"Zhang","year":"2004","journal-title":"Immunity"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272516301479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272516301479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:03:41Z","timestamp":1761203021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272516301479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"alternative-id":["S1357272516301479"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2016.06.007","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEF2C and CEBPA: Possible co-regulators in chronic myeloid leukemia disease progression","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}